Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Deferred consent in a minimal-risk study involving critically ill subarachnoid hemorrhage patients.

Topolovec-Vranic J, Santos M, Baker AJ, Smith OM, Burns KE.

Can Respir J. 2014 Sep-Oct;21(5):293-6. Epub 2014 Jun 10.

2.

Surrogate and patient discrepancy regarding consent for critical care research.

Newman JT, Smart A, Reese TR, Williams A, Moss M.

Crit Care Med. 2012 Sep;40(9):2590-4. doi: 10.1097/CCM.0b013e318258ff19.

3.

Research recruitment practices and critically ill patients. A multicenter, cross-sectional study (the Consent Study).

Burns KE, Zubrinich C, Tan W, Raptis S, Xiong W, Smith O, McDonald E, Marshall JC, Saginur R, Heslegrave R, Rubenfeld G, Cook DJ; Canadian Critical Care Trials Group.

Am J Respir Crit Care Med. 2013 Jun 1;187(11):1212-8. doi: 10.1164/rccm.201208-1537OC.

PMID:
23525935
4.

Ability of family members to predict patient's consent to critical care research.

Ciroldi M, Cariou A, Adrie C, Annane D, Castelain V, Cohen Y, Delahaye A, Joly LM, Galliot R, Garrouste-Orgeas M, Papazian L, Michel F, Barnes NK, Schlemmer B, Pochard F, Azoulay E; Famirea study group.

Intensive Care Med. 2007 May;33(5):807-13. Epub 2007 Mar 15.

PMID:
17361388
5.

A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial.

Burns KE, Chant C, Smith O, Cuthbertson B, Fowler R, Cook DJ, Kruger P, Webb S, Alhashemi J, Dominguez-Cherit G, Zala C, Rubenfeld GD, Marshall JC.

Trials. 2011 Mar 9;12:70. doi: 10.1186/1745-6215-12-70.

6.
7.

Obtaining surrogate consent for a minimal-risk research study in the intensive care unit setting.

Larkin ME, Beauharnais CC, Magyar K, Macey L, Grennan KB, Boykin EE, Russell SJ.

Clin Trials. 2013 Feb;10(1):93-6. doi: 10.1177/1740774512464727. Epub 2012 Nov 20.

PMID:
23169873
8.

Informed consent in the critically ill: a two-step approach incorporating delirium screening.

Fan E, Shahid S, Kondreddi VP, Bienvenu OJ, Mendez-Tellez PA, Pronovost PJ, Needham DM.

Crit Care Med. 2008 Jan;36(1):94-9.

PMID:
18090168
9.

Improving the process of informed consent in the critically ill.

Davis N, Pohlman A, Gehlbach B, Kress JP, McAtee J, Herlitz J, Hall J.

JAMA. 2003 Apr 16;289(15):1963-8.

PMID:
12697799
10.

A computer-based education intervention to enhance surrogates' informed consent for genomics research.

Shelton AK, Freeman BD, Fish AF, Bachman JA, Richardson LI.

Am J Crit Care. 2015 Mar;24(2):148-55. doi: 10.4037/ajcc2015983.

11.

Barriers to obtaining consent in dementia research: implications for surrogate decision-making.

Baskin SA, Morris J, Ahronheim JC, Meier DE, Morrison RS.

J Am Geriatr Soc. 1998 Mar;46(3):287-90.

PMID:
9514373
12.

Patients' preferences for enrolment into critical-care trials.

Scales DC, Smith OM, Pinto R, Barrett KA, Friedrich JO, Lazar NM, Cook DJ, Ferguson ND.

Intensive Care Med. 2009 Oct;35(10):1703-12. doi: 10.1007/s00134-009-1552-y. Epub 2009 Jun 24.

PMID:
19551372
13.

Surrogate consent for research involving adults with impaired decision making: survey of Institutional Review Board practices.

Gong MN, Winkel G, Rhodes R, Richardson LD, Silverstein JH.

Crit Care Med. 2010 Nov;38(11):2146-54. doi: 10.1097/CCM.0b013e3181f26fe6.

14.
15.

The effect of window rooms on critically ill patients with subarachnoid hemorrhage admitted to intensive care.

Wunsch H, Gershengorn H, Mayer SA, Claassen J.

Crit Care. 2011;15(2):R81. doi: 10.1186/cc10075. Epub 2011 Mar 3.

16.

The use of delayed telephone informed consent for observational emergency medicine research is ethical and effective.

Offerman SR, Nishijima DK, Ballard DW, Chetipally UK, Vinson DR, Holmes JF.

Acad Emerg Med. 2013 Apr;20(4):403-7. doi: 10.1111/acem.12117.

17.

The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.

Jensen JU, Lundgren B, Hein L, Mohr T, Petersen PL, Andersen LH, Lauritsen AO, Hougaard S, Mantoni T, Bømler B, Thornberg KJ, Thormar K, Løken J, Steensen M, Carl P, Petersen JA, Tousi H, Søe-Jensen P, Bestle M, Hestad S, Andersen MH, Fjeldborg P, Larsen KM, Rossau C, Thomsen CB, Ostergaard C, Kjaer J, Grarup J, Lundgren JD.

BMC Infect Dis. 2008 Jul 13;8:91. doi: 10.1186/1471-2334-8-91.

18.

Use of deferred consent for severely ill children in a multi-centre phase III trial.

Maitland K, Molyneux S, Boga M, Kiguli S, Lang T.

Trials. 2011 Mar 31;12:90. doi: 10.1186/1745-6215-12-90. Review.

19.

Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice.

Rosenbaum JR, Bravata DM, Concato J, Brass LM, Kim N, Fried TR.

Stroke. 2004 Sep;35(9):e353-5. Epub 2004 Jul 8.

20.

Perspectives of surrogate decision makers for critically ill patients regarding gene variation research.

Iverson E, Celious A, Kennedy CR, Shehane E, Eastman A, Warren V, Freeman BD.

Genet Med. 2013 May;15(5):368-73. doi: 10.1038/gim.2012.142. Epub 2012 Nov 15.

PMID:
23154525
Items per page

Supplemental Content

Write to the Help Desk